Orion Oyj/€ORNBV
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Orion Oyj
Orion Oyj, established in 1917 and headquartered in Espoo, Finland, is a globally operating pharmaceutical company specializing in the development, manufacturing, and marketing of human and veterinary pharmaceuticals, as well as active pharmaceutical ingredients (APIs). ([orion.fi](https://www.orion.fi/en/about-orion?utm_source=openai)) The company's product portfolio includes treatments for central nervous system disorders, oncology, respiratory diseases, and urology, with notable products such as Nubeqa for prostate cancer, Stalevo for Parkinson's disease, and the Easyhaler range for asthma and chronic obstructive pulmonary disease. ([stockanalysis.com](https://stockanalysis.com/quote/otc/ORINY/company/?utm_source=openai)) Orion operates production facilities in Finland, France, and Belgium, and maintains research centers in Finland, the UK, and the US. ([marketscreener.com](https://www.marketscreener.com/quote/stock/ORION-OYJ-1412508/news/Orion-Oyj-Sustainability-Report-orion-financial-statement-documents-2024-49296639/?utm_source=openai)) The company's strategic focus is on expanding its global presence through innovation and partnerships, aiming to address healthcare challenges such as cost pressures and an aging population. ([orion.fi](https://www.orion.fi/en/investors/orion-as-an-investment/strategy-and-purpose?utm_source=openai))
Ticker
€ORNBV
Sector
Primary listing
XHEL
Industry
Pharmaceuticals
Headquarters
Espo, Finland
Employees
3,943
ISIN
FI0009014377
Website
Orion Oyj Metrics
BasicAdvanced
€8.9B
25.68
€2.47
0.43
€1.63
2.57%
Price and volume
Market cap
€8.9B
Beta
0.43
52-week high
€64.25
52-week low
€38.15
Average daily volume
271K
Dividend rate
€1.63
Financial strength
Current ratio
3.788
Quick ratio
2.274
Long term debt to equity
27.259
Total debt to equity
30.109
Dividend payout ratio (TTM)
65.49%
Interest coverage (TTM)
52.57%
Profitability
EBITDA (TTM)
442.1
Gross margin (TTM)
61.54%
Net profit margin (TTM)
21.87%
Operating margin (TTM)
24.82%
Effective tax rate (TTM)
20.14%
Revenue per employee (TTM)
€400,000
Management effectiveness
Return on assets (TTM)
15.58%
Return on equity (TTM)
39.16%
Valuation
Price to earnings (TTM)
25.676
Price to revenue (TTM)
5.615
Price to book
8.35
Price to tangible book (TTM)
10.01
Price to free cash flow (TTM)
50.196
Free cash flow yield (TTM)
1.99%
Free cash flow per share (TTM)
126.47%
Dividend yield (TTM)
2.57%
Growth
Revenue change (TTM)
30.17%
Earnings per share change (TTM)
60.55%
3-year revenue growth (CAGR)
15.06%
10-year revenue growth (CAGR)
4.43%
3-year earnings per share growth (CAGR)
21.98%
10-year earnings per share growth (CAGR)
4.50%
3-year dividend per share growth (CAGR)
3.02%
10-year dividend per share growth (CAGR)
2.35%
Bulls say / Bears say
Orion Oyj's Q4 2024 net sales grew by 35.3% year-over-year, driven by the blockbuster success of Nubeka, which exceeded €1 billion in sales. (Investing.com)
The company's stock price surged by 6.39% following the earnings announcement, nearing its 52-week high, indicating strong investor confidence. (Investing.com)
Orion Oyj has maintained dividend payments for 18 consecutive years, currently offering a 3.12% yield, appealing to income-focused investors. (Investing.com)
Despite strong sales growth, Orion Oyj's net profit margin decreased by 27.81% in Q4 2024, raising concerns about profitability. (Google Finance)
The company's free cash flow was negative €73.11 million in Q4 2024, a decline of 245.69% year-over-year, indicating potential liquidity issues. (Google Finance)
Orion Oyj's debt-to-equity ratio stands at 0.25, which, while moderate, suggests a reliance on debt that could be risky in a rising interest rate environment. (MarketBeat)
Data summarised monthly by Lightyear AI. Last updated on 30 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Orion Oyj stock?
Orion Oyj (ORNBV) has a market cap of €8.9B as of June 30, 2025.
What is the P/E ratio for Orion Oyj stock?
The price to earnings (P/E) ratio for Orion Oyj (ORNBV) stock is 25.68 as of June 30, 2025.
Does Orion Oyj stock pay dividends?
Yes, the Orion Oyj (ORNBV) stock pays dividends to shareholders. As of June 30, 2025, the dividend rate is €1.63 and the yield is 2.57%. Orion Oyj has a payout ratio of 65.49% on a trailing twelve-month basis.
When is the next Orion Oyj dividend payment date?
The next Orion Oyj (ORNBV) dividend payment date is unconfirmed.
What is the beta indicator for Orion Oyj?
Orion Oyj (ORNBV) has a beta rating of 0.43. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.